Related Experiment Videos
Hepatocellular carcinoma: therapy and prevention
1Department of Medicine II, University of Freiburg, Hugstetter Strasse 55, D-79106 Freiburg, Germany. hubert.blum@uniklinik-freiburg.de
World Journal of Gastroenterology
|January 27, 2006
Summary
Hepatocellular carcinoma (HCC) remains a global challenge with stagnant survival rates due to late diagnosis and limited treatments. Novel systemic therapies, early detection, and prevention strategies are crucial for improving outcomes in liver cancer patients.
Area of Science:
- Hepatology
- Oncology
- Cancer Research
Background:
- Hepatocellular carcinoma (HCC) is a prevalent malignancy with well-defined risk factors, yet survival has not improved in 30 years.
- Late diagnosis and limited therapeutic options contribute to poor patient outcomes.
- Current treatments are often ineffective for advanced or multicentric HCC.
Purpose of the Study:
- To review current therapeutic strategies for hepatocellular carcinoma (HCC).
- To highlight the need for improved early diagnosis and novel systemic therapies for advanced HCC.
- To emphasize the importance of primary and secondary prevention of liver cancer.
Main Methods:
- Review of existing therapeutic interventions for HCC, including surgery, percutaneous, and transarterial approaches.
- Analysis of randomized controlled trials informing current treatment recommendations.
- Discussion of emerging technologies like gene expression profiling and proteomics.
Main Results:
- Surgery and interventional therapies are effective for early-stage HCC with compensated liver disease.
- Over 80% of patients present with advanced disease, limiting treatment options.
- Current therapeutic strategies have not significantly improved overall patient survival.
Conclusions:
- Early diagnosis and novel systemic therapies (drugs, gene, immune) are essential for advanced HCC.
- Improving primary and secondary prevention is critical for reducing HCC morbidity and mortality.
- Advanced molecular technologies offer potential for identifying new diagnostic and therapeutic targets.